137 related articles for article (PubMed ID: 31420696)
1. Outcomes for urologic oncology procedures: are there differences between academic and community hospitals?
Syed JS; Abello A; Nguyen J; Lee AJH; Desloges JJ; Leapman MS; Kenney PA
World J Urol; 2020 May; 38(5):1187-1193. PubMed ID: 31420696
[TBL] [Abstract][Full Text] [Related]
2. Hospital-level variation in the quality of urologic cancer surgery.
Gore JL; Wright JL; Daratha KB; Roberts KP; Lin DW; Wessells H; Porter M
Cancer; 2012 Feb; 118(4):987-96. PubMed ID: 21792864
[TBL] [Abstract][Full Text] [Related]
3. The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program.
Kaye DR; Ye Z; Li J; Herrel LA; Dupree JM; Ellimoottil C; Miller DC
Urology; 2019 Jan; 123():114-119. PubMed ID: 30125647
[TBL] [Abstract][Full Text] [Related]
4. Use and outcomes of extended antibiotic prophylaxis in urological cancer surgery.
Calvert JK; Holt SK; Mossanen M; James AC; Wright JL; Porter MP; Gore JL
J Urol; 2014 Aug; 192(2):425-9. PubMed ID: 24603103
[TBL] [Abstract][Full Text] [Related]
5. Readmissions after major urologic cancer surgery.
Leow JJ; Gandaglia G; Sood A; Ruhotina N; Klett DE; Sammon JD; Schmid M; Sun M; Chang SL; Kibel AS; Trinh QD
Can J Urol; 2014 Dec; 21(6):7537-46. PubMed ID: 25483761
[TBL] [Abstract][Full Text] [Related]
6. Mortality after urologic cancer surgery: impact of non-index case volume.
Gilbert SM; Dunn RL; Miller DC; Daignault S; Ye Z; Hollenbeck BK
Urology; 2008 May; 71(5):906-10. PubMed ID: 18372016
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and critique of the literature relating hospital or surgeon volume to health outcomes for 3 urological cancer procedures.
Nuttall M; van der Meulen J; Phillips N; Sharpin C; Gillatt D; McIntosh G; Emberton M
J Urol; 2004 Dec; 172(6 Pt 1):2145-52. PubMed ID: 15538220
[TBL] [Abstract][Full Text] [Related]
8. Inequity in selective referral to high-volume hospitals for genitourinary malignancies.
Berg S; Tully KH; Sahraoui A; Tan WS; Krimphove MJ; Marchese M; Lipsitz SR; Noldus J; Trinh QD
Urol Oncol; 2020 Jun; 38(6):582-589. PubMed ID: 32217041
[TBL] [Abstract][Full Text] [Related]
9. The impact of provider volume on outcomes from urological cancer therapy.
Joudi FN; Konety BR
J Urol; 2005 Aug; 174(2):432-8. PubMed ID: 16006859
[TBL] [Abstract][Full Text] [Related]
10. Multilevel Analysis of Readmissions After Radical Cystectomy for Bladder Cancer in the USA: Does the Hospital Make a Difference?
Cole AP; Ramaswamy A; Harmouch S; Fletcher SA; Gild P; Sun M; Lipsitz SR; Chiang HA; Haider AH; Preston MA; Kibel AS; Trinh QD
Eur Urol Oncol; 2019 Jul; 2(4):349-354. PubMed ID: 31277772
[TBL] [Abstract][Full Text] [Related]
11. Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United States.
Leow JJ; Reese SW; Jiang W; Lipsitz SR; Bellmunt J; Trinh QD; Chung BI; Kibel AS; Chang SL
Eur Urol; 2014 Sep; 66(3):569-76. PubMed ID: 24491306
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of head and neck cancer surgery in the geriatric population based on case volume at academic centers.
Jalisi S; Rubin SJ; Wu KY; Kirke DN
Laryngoscope; 2017 Nov; 127(11):2539-2544. PubMed ID: 28699223
[TBL] [Abstract][Full Text] [Related]
13. Health resource use after robot-assisted surgery vs open and conventional laparoscopic techniques in oncology: analysis of English secondary care data for radical prostatectomy and partial nephrectomy.
Hughes D; Camp C; O'Hara J; Adshead J
BJU Int; 2016 Jun; 117(6):940-7. PubMed ID: 26696305
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample.
Yu HY; Hevelone ND; Lipsitz SR; Kowalczyk KJ; Nguyen PL; Choueiri TK; Kibel AS; Hu JC
Eur Urol; 2012 Jun; 61(6):1239-44. PubMed ID: 22482778
[TBL] [Abstract][Full Text] [Related]
15. Quantifying Nonindex Hospital Readmissions and Care Fragmentation after Major Urological Oncology Surgeries in a Nationally Representative Sample.
Chappidi MR; Kates M; Stimson CJ; Bivalacqua TJ; Pierorazio PM
J Urol; 2017 Jan; 197(1):235-240. PubMed ID: 27460756
[TBL] [Abstract][Full Text] [Related]
16. Association of procedure volume with radical cystectomy outcomes in a nationwide database.
Barbieri CE; Lee B; Cookson MS; Bingham J; Clark PE; Smith JA; Chang SS
J Urol; 2007 Oct; 178(4 Pt 1):1418-21; discussion 1421-2. PubMed ID: 17706712
[TBL] [Abstract][Full Text] [Related]
17. Episode-based Payment Variation for Urologic Cancer Surgery.
Ellimoottil C; Li J; Ye Z; Dupree JM; Min HS; Kaye D; Herrel LA; Miller DC
Urology; 2018 Jan; 111():78-85. PubMed ID: 29051001
[TBL] [Abstract][Full Text] [Related]
18. Relationship of surgeon/hospital volume with outcomes in uro-oncology surgery.
Grande P; Campi R; Rouprêt M
Curr Opin Urol; 2018 May; 28(3):251-259. PubMed ID: 29461273
[TBL] [Abstract][Full Text] [Related]
19. Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system.
Basto M; Sathianathen N; Te Marvelde L; Ryan S; Goad J; Lawrentschuk N; Costello AJ; Moon DA; Heriot AG; Butler J; Murphy DG
BJU Int; 2016 Jun; 117(6):930-9. PubMed ID: 26350758
[TBL] [Abstract][Full Text] [Related]
20. The implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer.
Kim SP; Shah ND; Karnes RJ; Weight CJ; Frank I; Moriarty JP; Han LC; Borah B; Tollefson MK; Boorjian SA
J Urol; 2012 Jun; 187(6):2011-7. PubMed ID: 22498229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
